Four-dimensional ͑4D͒ radiotherapy is the explicit inclusion of the temporal changes in anatomy during the imaging, planning, and delivery of radiotherapy. Temporal anatomic changes can occur for many reasons, though the focus of the current investigation is respiration motion for lung tumors. The aim of this study was to develop 4D radiotherapy treatment-planning methodology for DMLC-based respiratory motion tracking. A 4D computed tomography ͑CT͒ scan consisting of a series of eight 3D CT image sets acquired at different respiratory phases was used for treatment planning. Deformable image registration was performed to map each CT set from the peak-inhale respiration phase to the CT image sets corresponding to subsequent respiration phases. Deformable registration allows the contours defined on the peak-inhale CT to be automatically transferred to the other respiratory phase CT image sets. Treatment planning was simultaneously performed on each of the eight 3D image sets via automated scripts in which the MLC-defined beam aperture conforms to the PTV ͑which in this case equaled the GTV due to CT scan length limitations͒ plus a penumbral margin at each respiratory phase. The dose distribution from each respiratory phase CT image set was mapped back to the peak-inhale CT image set for analysis. The treatment intent of 4D planning is that the radiation beam defined by the DMLC tracks the respiration-induced target motion based on a feedback loop including the respiration signal to a real-time MLC controller. Deformation with respiration was observed for the lung tumor and normal tissues. This deformation was verified by examining the mapping of high contrast objects, such as the lungs and cord, between image sets. For the test case, dosimetric reductions for the cord, heart, and lungs were found for 4D planning compared with 3D planning. 4D radiotherapy planning for DMLC-based respiratory motion tracking is feasible and may offer tumor dose escalation and/or a reduction in treatment-related complications. However, 4D planning requires new planning tools, such as deformable registration and automated treatment planning on multiple CT image sets.
I. INTRODUCTION
The advent of four-dimensional ͑4D͒ thoracic CT scans that create separate CT images at discrete phases of the respiratory cycle [1] [2] [3] [4] [5] [6] [7] [8] [9] introduces the issue of how best to use this information ͑typically over 1000 slices for a full 4D CT scan of the thorax͒ for radiation therapy planning. The use of multiple sequential CT data sets to improve radiotherapy's ability to account for interfraction motion, termed "adaptive" radiotherapy, has been discussed by Yan et al. , [10] [11] [12] [13] [14] University of Wisconsin reports, [15] [16] [17] [18] [19] and others. 20, 21 In this approach, positioning and dosimetric information from CT scans acquired during treatment is used to vary patient positioning and/or the treatment beams for subsequent treatments. Such strategies allow improved target coverage and/or normal tissue dose reduction. 4D radiotherapy planning to account for respiratory motion applies concepts of adaptive radiotherapy to a 4D CT data set, given that the radiation treatment beam will track the respiration-induced anatomical changes during treatment. In 4D radiotherapy planning, different treatment plans are generated for different respiratory phases with the constraints of the treatment device's ability to deliver these plans. This definition is consistent with that of the consensus of the AS-TRO 2003 "Time-the 4th dimension in radiotherapy" panel that 4D radiotherapy is the "explicit inclusion of the temporal changes of anatomy during the imaging, planning and delivery of radiotherapy." 22 Note that the definition of 4D radiotherapy planning defined here differs from that discussed by Shirato et al.; 23 of the breath-hold and freebreathing CT scans acquired in their study, only one was used for treatment planning. Though the tumor tracking of an implanted fluoroscopic marker via x-ray is real-time, the treatment delivery itself is gated. [24] [25] [26] [27] [28] [29] [30] [31] The aim of this research was to develop 4D radiotherapy planning methodology to account for respiratory motion using DMLC-based tumor tracking and provide a proof-ofprinciple example of 4D radiotherapy planning.
II. METHODS AND MATERIALS

A. 4D CT image
The 4D CT patient image acquired and used for this study is described in detail in the publication by Vedam et al. 2 The patient was a 50-year-old male with stage IIB non-small cell lung cancer located in the right hilum. The 4D CT consisted of eight discrete respiratory phases: peak inhale, early exhale, mid exhale, late exhale, peak exhale, early inhale, mid inhale, and late inhale. Due to both tube heat and reconstruction time limitations, only a 10.5 cm region of the patient's anatomy was scanned, covering the gross tumor volume ͑GTV͒. On the peak-inhale CT image, the following anatomy was defined: GTV, lungs, heart, and the spinal cord. The PINNACLE treatment-planning system ͑Philips Medical Systems, Milpitas, CA͒ was used. The choice of using the peakinhale CT image for the reference is somewhat arbitrary, however it is advisable to use either peak inhale or peak exhale as these phases have the fewest motion artifacts on 4D CT. Because the scan only covered a 10.5 cm range, to ensure that the planning target volume ͑PTV͒ did not extend outside the CT volume, the PTV was assumed to equal the clinical target volume ͑CTV͒, which was assumed to be equal to the GTV. Though this assumption is unrealistic for clinical radiotherapy, to achieve the aims of this study, the assumption was deemed acceptable.
B. Deformable image registration
Large deformation diffeomorphic image registration [32] [33] [34] [35] [36] [37] was used to map with a one-to-one correspondence all points in the CT image from one respiratory phase ͑peak inhale͒ with corresponding points on the other respiratory phases, accommodating for the anatomic deformation caused by respiration. Let ⍀ be the coordinate space of the peak-inhale CT image. A time index transformation, h͑x , t͒ : ⍀ t → ⍀, mapping the coordinate space of each of the respiratory phases of the 4D CT is estimated. The transformation is constrained to be one to one while accommodating large deformations by expressing it as a solution to a viscous-fluid, ordinary differential equation:
where v͑h , t͒ is the velocity field. It is assumed that the CT number of the tissue undergoing deformation remains constant within the respiratory cycle and tissue deformation can be tracked by directly correlating the CT images at different phases of respiration using a minimum mean squared error metric: F͑h͒ = ͐ ⍀ ͉I A ͑h͑x , t͒͒ − I B ͑x͉͒ 2 dx, the difference between the intensities in the transformed image I A and image I B . Should the approximation of constant tissue density prove not to be valid, adding a term f͑I A ͒ to I A ͑h͑x , t͒͒ in F͑h͒ would improve the algorithm. f͑I A ͒ should be inverse Jacobian of the transformation h as the Jacobian measures the local volume change, and density is inversely proportional to volume. The inclusion of this term significantly increases the complexity of the minimization problem, and is the subject of ongoing research. Note also that as the anatomy included in the CT data sets obtained differ near the boundaries, some interpolation of the deformation fields near the edges of the data sets is performed. The accuracy of this process has yet to be sufficiently quantified.
The transformation h is estimated in a manner that minimizes the metric D͑h͒ while at the same time constraining the transformation to satisfy the laws of continuum mechanics, derived from viscous-fluid modeling using the NavierStokes equations on the velocity fields. Having computed the transformation h that maps the peak-inhale CT onto each of the respiratory phases of the 4D CT, the segmentation for each of the respiratory phases is accomplished by applying the transformation to the contours ͑i.e., physician-drawn contours͒ of the peak-inhale CT. The transformation h thus quantifies the organ motion and the fine-featured organ shape changes that occur during the breathing cycle. Verification of deformation registration on contours was performed by visual inspection of those structures with sharp anatomical contrast boundaries, i.e., the external skin contour, the lungs, and the spinal cord. These contours represent structures that move little with respiration ͑e.g., the cord in supine position͒ and structures that move significantly with respiration ͑e.g., the lungs͒. Quantification of the difference between manually defined anatomical points and those automatically determined using the deformable image registration was performed. Four anatomic points were chosen: a bifurcation in a left lower lobe vessel, the lateral aspect of a right lower lobe bronchiole just proximal to a bifurcation, the anterior-most aspect of the vertebral body at the level of the carina, and the right nipple. The first two points represent structures in the lung likely to move with respiration, the third point is a control, and the fourth point represents chest wall motion. These points were manually contoured on each respiratory phase CT set. Taking the points defined on the endinspiration CT image set, the points were automatically determined on subsequent respiratory phase CT image sets using the transformations from the deformable image registrations.
In a separate study using this algorithm, 38 the accuracy of the deformation process was quantified by comparing it to manual segmentation for inhale and exhale CT scans of six lung cancer patients. The results yielded a median error of 0.7 mm and a 95% confidence error of 3.1 mm, with the errors largest in the superior-inferior direction. This is ex-pected for two reasons: the CT resolution is significantly poorer in this direction ͑the 95% confidence interval error is of the order of the CT scan resolution͒, and this is also the predominant direction of tumor motion.
Scripts were written to allow information associated with one CT image set, such as anatomic contours and dose distributions, to be transferred to other respiratory phases of the 4D CT via the deformation field. These scripts consist of programs that extract data from the treatment-planning system, such as contours or dose distributions associated with one CT image set, operate on this data via the transformations described in the following, and input the transformed contours/dose distributions back into the treatment-planning system. The interactions with the treatment-planning system used the PinnComm scripting language, which is available with PINNACLE. Thus, the contours defined on the peakinhale CT image were transferred to the other respiratory phase of the 4D CT by passing through the deformable image registration operator, as shown in Fig. 1 . Due to limitations of the contour storage structure of the treatmentplanning system for 4D planning applications, the x and y ͑in-slice͒ points were deformed correctly, however, an average z deformation ͑the average of the individual z deformation of constituent in-slice contour points͒ was used. This limitation will be eliminated in future versions of PINNACLE. 39 After treatment planning was performed for each respiratory phase ͑see section below for specific planning details͒, the dose distribution for each CT phase was transformed back to the peak-inhale CT image set for evaluation of the entire treatment plan accounting for all respiratory phases, where the combined or 4D dose distribution, D 4D , is given by
where w i is the fractional weight of the dose distribution D i for each of the ͕A , ... ,H͖ CT phases. For this study, equal weighting was used for each phase, as approximately equal numbers of images were assigned for each phase. 2 However, in general the w i values will not be equal. Further information on the use of deformable image registration for dose accumulation can be found in Refs. 33 and 40-52.
C. Treatment planning
A six-field coplanar nonopposed conformal plan was developed on the peak-inhale phase, with the beam angles predominantly in the anterior direction ͑angles 20°, 140°, 180°, 220°, 300°, and 340°͒. 6 MV energy was used for all beams. No wedges were used for the fields. The multileaf collimator was aligned in the superior-inferior direction, which has been noted to be the predominant direction of motion for lung tumors. [53] [54] [55] [56] [57] A 0.8 cm margin was added outside the PTV to account for penumbral effects, and the multileaf collimator was used to define the field boundary. The beam weights were manually selected to give a reasonably uniform PTV dose with acceptable critical structure doses.
Automated scripts were written using the PinnComm scripting language and external programs to transfer the treatment plan for the peak-inhale CT for each of the other respiratory phases. The autoblocking utility of the treatmentplanning system allowed conformality of the field shape to the PTV in each respiratory phase, as shown in Fig. 2 for two phases of the posterior beam. To create the final combined 4D plan, the dose for each constituent respiratory phase was summed via deformable image registration. For this approach the beams weights used for the manually planned phase were the same for each automatically planned respiratory phase. It would be possible ͑though not investigated here͒ to optimize the beam weights for the 4D plan which may further improve the plan quality.
To create the 3D plan, the PTV for each of the respiratory phases was superimposed, i.e., the 3D PTV is the union of each 4D PTV phase. The treatment plan for the peak-inhale phase was the same as that used for the 4D plan, except that the fields conformed to the 3D PTV as shown in Fig. 2 . The 3D vs 4D comparison performed here is a "best-case" comparison for 3D in that no extra margins were added to account for the artifacts during imaging, 1,2,27,58-64 and additional internal margins were required to ensure that the CTV was adequately dosed during delivery in which respiratory motion occurred. It should also be noted that a clinical 4D treatment plan should have additional geometric margins to account for the errors in the deformable image registration process and also the ability of the DMLC to track the moving target. [65] [66] [67] The 3D and 4D treatment plans are compared in Sec. III. 
III. RESULTS
A. Deformable image registration
The comparison of the deformable image registration algorithm results compared with points manually defined on each respiratory phase are shown in Fig. 3 . The differences between the manual and automatically defined points were within one CT slice thickness ͑0.4 cm͒ for all points studied. It is interesting to note that the displacements predicted by deformable registration showed smaller variations from phase to phase than the manually defined points.
The 4D PTVs in axial, coronal, and sagittal views at four phases of the respiratory cycle are shown in Fig. 4 . The volumes encompassed by the skin, heart, PTV, and lungs at each respiratory phase are given in Fig. 5 . Note that the normal tissue values shown in Fig. 5 are limited to the volume within the CT scan ͑10.5 cm in length͒, which did not encompass the entire thorax. The PTV volumes are fairly constant apart from the early inspiration phase value that is approximately 7% smaller than the other volumes. It is unclear if this low value is an artifact of the 4D CT itself, the deformable image registration algorithm, or simply due to variations introduced by the 4 mm CT slice thickness. The lung volumes change as expected with respiration. The volume encompassed by the skins stays nearly constant ͑less than 35 cc change with respiration͒ for the CT scan length, though we would expect for a full thoracic CT scan that the volume would change by the volume of air inhaled ͑account-ing for pressure differences͒. The heart changes by less than 5% from the mean volume, and is also influenced by cardiac motion. The cord changes by less than 0.5 cc from the mean volume.
The centroid of the 4D PTV for each respiratory phase is shown in Fig. 6 , giving evidence of cyclic motion as observed in the fluoroscopic implanted marker study of Seppenwoolde et al. 53 Note that the minimum and maximum superior-inferior positions of the PTV centroid do not coincide with the peak inhale and peak exhale positions as determined from the respiratory signal. Thus there is evidence of a phase shift between the internal motion and the respiratory signal. This phase shift itself does not degrade the 4D plan, however, variations in the phase shift, or more generally variations in the correlation between the internal motion and respiratory signal, would negatively impact the accuracy of the 4D delivery.
B. 4D treatment plan
The dose distribution for each CT phase and the dose distribution transformed back to the peak-inhale CT image set for evaluation of the entire treatment plan compiled for all respiratory phases ͑the 4D plan͒ is shown in Fig. 7 . The dose distributions in each phase are fairly similar due to the relatively ͑Ͻ10% ͒ small change in overall volume of the PTV for each respiratory phase, and the adaptation of the treatment plan to these positional and volumetric PTV changes.
Dose-volume histograms ͑DVHs͒ for each constituent breathing phase and for the combined dose distribution ͑found by summing the constituent dose distributions via deformable operators͒ are given in Fig. 8 for the PTV, lungs, cord, and heart. The DVHs for the PTV at all phases and the combined ͑4D͒ DVH are all very similar ͑note the expanded x-axis scale͒. The lung DVHs are closely bunched, with the combined 4D DVH closer to the end-inhale DVH due to the fact that DVHs typically use normalized rather than absolute volumes, and that the entire lung was not included in the CT scan. The 4D DVHs for the cord and heart appear to be near the middle of the constituent-phase DVHs. The variation in cord and heart DVHs for the constituent phases is due to the change in beam aperture with respiratory phase and, hence, the fraction of the organ intersecting the beam passing through these structures, as the PTV deforms with respiratory phase. Note that the 4D cord DVH seems to exceed all 3D DVHs around 10 Gy. This is possible due to the dose summation to obtain the 4D dose, in that the 4D DVH will show the maximum of the minimum dose in any phase. Tak- 4 . The PTV contoured on the computed tomography ͑CT͒ anatomy in axial view ͑a͒-͑d͒, coronal view ͑e͒-͑h͒, and sagittal view ͑i͒-͑l͒. The four respiration phases shown are peak inhale ͑a͒, ͑e͒, and ͑i͒; mid exhale ͑b͒, ͑f͒, and ͑j͒; peak exhale ͑c͒, ͑g͒, and ͑k͒; and mid inhale ͑d͒, ͑h͒, and ͑l͒. Note that the anatomy was explicitly contoured on the peak-inhale images, and the PTVs on the other breathing phases were automatically created based on the deformable registration transformations.
ing a simple example of a two voxel structure with doses of 0 and 1, then the minimum dose in any voxel will be 0, but the minimum dose in the summed/averaged voxel can be greater than 0. For example, phase A has doses 0 and 1, phase B has doses of 1 and 0, then the 4D dose would be 0.5 and 0.5 in the two voxels, respectively.
C. 3D vs 4D
A comparison of the 3D PTV and peak-inhale PTV is given in Fig. 9 . As expected, the 3D PTV is larger than the peak-inhale-phase PTV. DVHs for the 3D and 4D treatment plans are seen Fig. 10 . The isodose distributions appear to be relatively similar for the central axis slice shown. However, the DVHs show dosimetric reductions for the lungs, heart, and cord for the 4D plan. Though the comparisons here show somewhat modest gains for 4D vs 3D planning, as expanded upon in Sec. IV, the current comparisons do not include artifacts during conventional CT imaging, which are a known source of error.
IV. DISCUSSION
A 4D treatment-planning process for DMLC-based respiratory motion tracking has been developed and applied to an existing 4D CT image. Dosimetric advantages were found for the 4D treatment plan compared with the 3D plan for nontarget structures. Though no general conclusions can be drawn from the single proof-of-principle example case demonstrated here, clearly, if the respiratory motion is explicitly accounted for during the imaging, planning, and delivery of radiotherapy, some dosimetric improvements are expected. Applying the 4D planning method to a larger patient cohort is required to quantify the potential gains for 4D radio- FIG. 5 . The volumes of the entire computed tomography ͑CT͒ anatomy in each of the eight respiratory phases: ͑a͒ PTV, ͑b͒ lungs ͓minus the gross tumor volume ͑GTV͔͒, ͑c͒ heart, ͑d͒ cord, and ͑e͒ skin. Note that the entire volumes of organs ͑b͒-͑e͒ were not included in the 4D CT scan due to acquisition limitations.
therapy, both compared with conventional 3D treatments and also respiratory gated and breath-hold treatments.
Without automated tools, an order-of-magnitude increase in workload for 4D treatment planning over 3D planning is required due to the order-of-magnitude increase in input data and tasks such as contouring multiple data sets, creating treatment plans on these data sets, and analyzing the dose distribution for each of these images. Such an increase is neither desirable nor feasible. The tools that can reduce this workload to essentially that of a 3D treatment plan are deformable image registration and automated planning. Deformable image registration tools for radiotherapy purposes are relatively new and untested. As with any process, geometric uncertainties in the registration method will need to be quantified and taken into account during the planning process. Development and testing of these algorithms on multiple 4D CT sets is required for these tools, which will become an integral part of treatment-planning software as the field moves toward image-guided adaptive and 4D radiotherapy. Indeed, combining dose distributions without tools that map corresponding anatomical points in different data sets is problematic. Planning for 4D radiotherapy must account for the geometric uncertainties not accounted for by the respiratory tracking. Such uncertainties include setup error and interfraction motion as well as the 4D-specific uncertainties such as artifacts in 4D CT scans, 9,68 deformable image registration accuracy, 38 variations in respiratory signal and internal anatomy motion, [69] [70] [71] [72] motion prediction errors, [73] [74] [75] and a quantification of the DMLC positional and temporal accuracy as it is being operated in a mode that it was not initially designed for. Obviously, for 4D radiotherapy to be a viable option the sum of these geometric uncertainties should be significantly less than the sum of the geometric uncertainties for 3D radiotherapy.
There are both similarities and differences between 4D radiotherapy that accounts for respiratory motion and adaptive radiotherapy that accounts for interfraction displacements. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Both 4D and adaptive radiotherapy plan on multiple CT images, require dose calculation on multiple CT images, and require deformable registration and methods to obtain integral dose distributions and DVHs. However, 4D radiotherapy is delivering radiation to a moving target and, thus, is affected by beam-delivery system constraints, such as MLC velocity and acceleration limitations, that do not affect adaptive radiotherapy. For IMRT optimization, 4D radiotherapy allows optimization on several data sets simultaneously and within the leaf motion constraints, whereas adaptive radiotherapy is restricted to optimization on current data sets with knowledge of previous data sets. With the similarities and commons tools required for 4D and adaptive radiotherapy, these techniques are complementary rather than contradictory. The 4D planning method described in this article is sensitive to variations in the respiratory surrogate used and the target anatomy motion. Adaptive radiotherapy strategies, which for 4D radiotherapy would involve reacquiring the 4D image of the patient and the respiration signal, and hence reacquiring the correlation, would reduce this sensitivity ͑and also provide valuable information as to the magnitude of this effect͒.
Using 4D radiotherapy to explicitly account for the change in target shape with respiration by varying the MLC positions logically leads to the concept of the 4D PTV, where the PTV for a given respiratory phase is fixed in space, per the ICRU definition; 76, 77 however, the PTV changes with time. The 4D PTV concept is analogous in adaptive radiotherapy, where the PTV changes with time due to interfractional changes in the GTV position and shape.
Apart from applying the 4D radiotherapy planning method to a significant number of patient cases, the next logical step is to develop a 4D IMRT planning methodology, [65] [66] [67] though due to beam-delivery system constraints, such as leaf acceleration and velocity limitations, the leaf sequencing for a 4D IMRT plan is nontrivial. The delivery aspects of 4D treatment plans 66, 67, 73, 74, [78] [79] [80] [81] including respiration prediction to account for the system response time have not been addressed here and are the subject of ongoing investigations.
Reproducibility in respiratory patterns during the imaging and delivery of 4D radiotherapy is an important issue requiring further investigation. Irreproducible respiration patterns may preclude some patients as candidates for 4D radiotherapy, whilst breathing training techniques 82 may be required for the majority of lung cancer patients in order to maintain breathing regularity over a protracted course of therapy. Since extracranial stereotactic radiotherapy ͑ESR͒ techniques [83] [84] [85] [86] [87] [88] [89] [90] have a much shorter duration of therapy, this cohort of patients may be most suitable for initial clinical testing of 4D radiotherapy. This reduction in overall treatment time means that the respiration reproducibility requirements are only for a week or so as opposed to six or more weeks of standard therapy. Another advantage of applying 4D radiotherapy to ESR patients is that the lesions are typically smaller than those treated with conventional therapy; thus, the ratio of respiratory-induced motion to the tumor volume is higher and the fractional improvement with 4D radiotherapy over standard delivery will be higher. Also, with the condensed course of therapy for ESR patients, typically more resources per fraction are utilized, and, thus, potentially resource-intensive strategies, such as 4D radiotherapy, can be employed. FIG. 9 . The 4D PTV for the peak-inhale phase ͑dark shading͒, and the 3D PTV created by combining the PTVs from all respiratory phases ͑light shading͒. The axial ͑a͒, coronal ͑b͒, and sagittal ͑c͒ views are shown. Note the total volumes for the peak-inhale PTV is 197 cm 3 , and the 3D PTV 237 cm 3 .
Though not explicitly part of this manuscript, the delivery of 4D radiotherapy using DMLC-based respiratory motion tracking should be mentioned here. Based on respiratory physiology literature, [91] [92] [93] [94] [95] [96] [97] and our institutional study collecting 330 respiratory motion traces from lung cancer patients, 98 cycle-to-cycle and day-to-day variations in respiration occur. Thus a feedback loop ͑see for example Fig. 8 in Ref. 99͒ acquiring the patient's respiratory signal and feeding this information to a four-dimensional controller which communicates in real-time with the MLC will be required. Varying breathing patterns during delivery, compared with those measured during the 4D CT imaging session used for treatment planning, mean that the planned and delivered doses may differ. For example, if the time spent within each breathing phase during treatment delivery, w d , differs from that during planning where fraction w i was used for the final dose calculation, the combined 4D dose will change following Eq. ͑1͒. However, using Eq. ͑1͒ with w d means that the actual dose delivered to the moving tumor and critical structures for each treatment fraction can be calculated. A problem appears if the respiration pattern limits during delivery exceed those obtained during the 4D CT session used for planning. Should such a situation occur, either the treatment should be paused until the respiration pattern returns within the limits known from planning ͑the prudent approach͒ or until a reasonable extrapolation of the tumor position and shape based on the respiratory signal can be made.
V. CONCLUSION
4D radiotherapy planning for DMLC-based respiratory motion tracking has been shown to be feasible and may offer tumor dose escalation and/or a reduction in treatment-related complications. In principle, 4D planning requires little more human interaction time than a 3D plan, however, new planning tools such as deformable registration and automated treatment planning on multiple CT image sets are required.
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